Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 26 October 2010
Vol. 3, Issue 145, p. pc19
[DOI: 10.1126/scisignal.3145pc19]


Science Signaling Podcast: 26 October 2010

Sonja Vermeren1 and Annalisa M. VanHook2

1 née Krugmann, Inositide Laboratory, The Babraham Institute, Cambridge CB22 3AT, UK.
2 Web Editor, Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.

Abstract: This is a conversation with Sonja Vermeren about a Research Article published in the 26 October 2010 issue of Science Signaling. Gambardella et al. report that mice lacking ARAP3 or expressing a form of ARAP3 that cannot be activated by PtdIns(3,4,5)P3 had defects in sprouting angiogenesis. ARAP3 is therefore a potential target for anti-angiogenic therapies.

Citation: S. Vermeren, A. M. VanHook, Science Signaling Podcast: 26 October 2010. Sci. Signal. 3, pc19 (2010).

Read the Full Text

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882